CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues:
Total revenues	$ 1,532,782	$ 1,604,354
Expenses:
General and administrative	65,956	76,422
Depreciation and amortization	6,876	5,844
Total expenses	1,554,892	1,611,532
Income (loss) from operations	(22,110)	(7,178)
Other income (expense):
Income (loss) from equity method investments	12,672	5,684
Other income (expense), net	9,261	5,892
Interest expense	(1,515)	(1,284)
Income (loss) before income taxes	(1,692)	3,114
Income tax benefit (expense)	(196)	133
Income (loss) from continuing operations	(1,888)	3,247
Discontinued operations:
Income (loss) before gain (loss) on sales	0	(518)
Adjustments on sale of assets, net	14,000	(8,763)
Total discontinued operations	14,000	(9,281)
Net income (loss)	12,112	(6,034)
Noncontrolling interests’ share in (earnings) loss	0	(30)
Net income (loss) attributable to common shares	$ 12,112	$ (6,064)
Net income (loss) per common share, basic and diluted
Continuing operations, basic (US dollar per share)	$ 0	$ 0.01
Continuing operations, diluted (US dollar per share)	0	0.01
Discontinued operations, basic (US dollar per share)	0.03	(0.02)
Discontinued operations, diluted (US dollar per share)	$ 0.03	$ (0.02)
Weighted average shares outstanding – basic (in shares)	412,936	408,938
Weighted average shares outstanding – diluted (in shares)	412,936	408,938
Medical services revenue
Revenues:
Total revenues	$ 1,529,879	$ 1,601,195
Expenses:
Expenses	1,401,867	1,443,842
Other operating revenue
Revenues:
Total revenues	2,903	3,159
Expenses:
Expenses	$ 80,193	$ 85,424